US and China clash over fentanyl and tariffs at global drugs meeting - Reuters

The United States and China engaged in a public dispute over fentanyl and trade tariffs during a global drugs meeting in Vienna. U.S. representatives accused China of failing to curb precursor chemical exports, which contribute to fentanyl production, and criticized its retaliatory tariffs on American goods. China countered by stating it has taken significant steps against drug trafficking and urged the U.S. to lift its sanctions on Chinese anti-drug agencies. This exchange highlights ongoing diplomatic tensions and divergent approaches to international drug control efforts. The disagreements complicate global cooperation on combating illicit drug flows.